Data / Form D filings / GENELINK INC
GENELINK INC: Form D filings
GENELINK INC, a biotechnology company in Orlando, FL, filed 7 Form D notices with the SEC between 2009 and 2013. The latest, on April 15, 2013, reports $50,000 sold of a $600,000 offering to 1 investor.
Find out what GENELINK INC does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 8250 EXCHANGE DRIVE, SUITE 120, Orlando, FL, 32809
- Phone
- (800) 588-4363
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Pennsylvania
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506
- SEC identifier (CIK)
- 941020
The full lists. Form D filings in Florida: 2,702 rows, $107.02, or the new rows each week for $19 a month. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Apr 15, 2013 | New notice | $600,000 | $50,000 | $550,000 | 1 | Apr 4, 2013 | sec.gov |
| Oct 9, 2012 | Amendment | $1,750,000 | $1,575,000 | $175,000 | 6 | Jun 20, 2012 | sec.gov |
| Jul 19, 2012 | New notice | $1,500,000 | $215,000 | $1,285,000 | 2 | Jun 20, 2012 | sec.gov |
| Jan 10, 2011 | New notice | $1,500,000 | $465,000 | $1,035,000 | 5 | Dec 30, 2010 | sec.gov |
| Feb 18, 2010 | New notice | $5,000,000 | $150,000 | $4,850,000 | 6 | Feb 17, 2010 | sec.gov |
| Nov 19, 2009 | New notice | $1,000,000 | $260,500 | $739,500 | 6 | Nov 12, 2009 | sec.gov |
| Jun 24, 2009 | New notice | $1,500,000 | $42,500 | $1,457,500 | 3 | Jun 12, 2009 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Robert P. Ricciardi | Executive Officer, Director | |
| James A Monton | Director | |
| Bernard L. Kasten | Executive Officer, Director | |
| Douglas M. Boyle | Director |
Other biotechnology companies in Florida that filed recently
- AdhereBio LLC offering · Oct 26, 2026
- Ascoltare Holdings LLC $1.7 million · Oct 23, 2026
- Immorta Bio, Inc. $612,503 · Oct 16, 2026
- CURADEL SURGICAL INNOVATIONS, INC. $49.8 million · Oct 13, 2026
- BioStem Technologies, Inc. $3 million · Oct 9, 2026
- HCW Biologics Inc. $1.5 million · Oct 8, 2026
- RHEOS MEDICAL CORP. $387,773 · Oct 7, 2026
- DIGITAL ETHER COMPUTING, LLC $625,000 · Sep 23, 2026
- Jupiter Biomedical Research, Inc. $30,000 · Sep 21, 2026
- Kaida BioPharma Inc. $1.6 million · Sep 1, 2026
- StrataBio Inc. $25,000 · Aug 31, 2026
- LUREX BIO, INC $150,000 · Aug 31, 2026
- EXUMA Biotech Corp. $70 million · Aug 20, 2026
- CRESCEL LLC $1.1 million · Aug 19, 2026
- EnduraFAST Inc. $50,000 · Aug 17, 2026
Every Form D from the week of Apr 15, 2013 · All recent filings in Florida · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what GENELINK INC reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.